NanoDimension

  • Bind
  • Blend
  • Crocus Technology
  • SBA Materials
  • Selecta Biosciences
  • View Inc.
  • Xtellus

Bind

BIND Therapeutics is a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called Accurins.

Company

Founder

Dr. Bob Langer
Dr. Omid Farokhzad

ND Board Member

Location

Cambridge, MA, USA

CEO

Scott Minick

Blend

Blend Therapeutics is a biopharmaceutical company discovering new classes of medicines using a proprietary integrative approach to design superior drugs.

Company

Founder

Dr. Bob Langer
Dr. Omid Farokhzad
Dr. Stephen Lippard

ND Board Member

Location

Watertown, MA, USA

CEO

Mark Iwicki

Crocus Technology

Crocus Technology is a leading developer of magnetically enhanced semiconductor technology.

Company

ND Board Member

Location

Grenoble, France
Sunnyvale, CA, USA

CEO

Dr. Bertrand Cambou

SBA Materials

SBA Materials is developing functional porous inorganic and inorganic/organic hybrid materials for a wide range of technologies.

Company

ND Board Member

Location

Albuquerque, NM, USA

CEO

Mr. William Cook

Selecta Biosciences

Selecta Biosciences is a clinical-stage biotechnology company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications.

Company

Founder

Dr. Bob Langer
Dr. Omid Farokhzad
Dr. Uli von Andrian

ND Board Member

Location

Watertown, MA, USA

CEO

Dr. Werner Cautreels

View Inc.

View Inc. manufactures View Dynamic Glass, an intelligent glass system for residential and commercial buildings.

Company

ND Board Member

Location

Milpitas, CA, USA
Olive Branch, MS, USA

CEO

Dr. Rao Mulpuri

Xtellus

Xtellus is a manufacturer of wavelength blockers and wavelength selective switches for reconfigurable optical add/drop multiplexers in fiber-optic networks.

Company

Xtellus

Location

Morris Plains, NJ, USA

Acquired by Oclaro (Nasdaq: OCLR) in 2009